Respiratory

Latest News

Wildfire smoke | Image credit: Aleksandr Lesik - stock.adobe.com

Smoke Pollution Linked to Increase in Hospitalizations in Older Adults

By Julia Bonavitacola

April 30th 2025

Respiratory diseases made up the hospitalizations in older adults after they were exposed to wildfire smoke.

cigarettegraphic | Image Credit: © freshidea-stock.adobe.com

Health Gains From US Smoking Decline Fall Short of Expectations

By Maggie L. Shaw

April 28th 2025

Nerandomilast is an investigational oral, preferential inhibitor of phosphodiesterase 4B that has shown promise in IPF and PPF. | Image credit: Елена Бутусова - stock.adobe.com

Nerandomilast Improves Lung Function in Progressive Pulmonary Fibrosis: FIBRONEER-ILD

By Rose McNulty

February 13th 2025

Sanofi | Image credit: Eagle - stock.adobe.com

Combination Influenza and COVID-19 Vaccine Candidates Granted Fast Track Designation

By Pearl Steinzor

December 16th 2024

Group of diverse kids | Image Credit: © EKKAPON-stock.adobe.com

Ambient Toxins Linked to Disabilities in Minority Schoolchildren

By Maggie L. Shaw

December 10th 2024

Continuing Medical Education

View All

April 30th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

April 29th 2022

FDA Proposes Standards Prohibiting Menthol Cigarettes, Flavored Cigars

Hayden E. Klein

The FDA proposed product standards prohibiting menthol flavor in cigarettes and all flavoring in cigars as part of the Cancer Moonshot initiative.

Patsy Stinchfield, RN, MS, CPNP, and William Schaffner, MD

April 28th 2022

NFID Board Members Explain Their Hopes for the Future of RSV Treatment, Prevention

Hayden E. Klein

William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain what strategies they look forward to being implemented in the prevention and treatment of respiratory syncytial virus (RSV).

April 20th 2022

Review Highlights Need for Stricter Health Policies Amid Rising e-Cigarette Use

Hayden E. Klein

According to a review, the availability of electronic cigarettes and vaping products to young people needs to be limited.

Roxana Siles, MD, FAAAAI, Cleveland Clinic

April 20th 2022

Dr Roxana Siles Discusses Chronic Cough Treatment and Its Adverse Effects

Maggie L. Shaw

Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the challenges of treating chronic cough.

April 14th 2022

Chronic Cough Linked to Disproportionate Depressive Symptoms, Study Finds

Hayden E. Klein

For adults with a history of depression, chronic cough can increase the risk of recurrent depressive events, a study found.

April 12th 2022

Dr Roxana Siles: Multispecialty Management of Chronic Cough Maximizes Patient Benefits

Maggie L. Shaw

Roxana Siles, MD, FAAAAI, staff in the Department of Allergy and Immunology at Cleveland Clinic and codirector of the Asthma Center at Cleveland Clinic, addresses the factors that contribute to necessitating multispecialty management of patients with chronic cough.

April 9th 2022

Pollutant Particle Size Affects Deposition in the Lung, Study Finds

Hayden E. Klein

Pollutant particles with a smaller diameter, density, and flow rate can enter the deep lung, but large particles with a low density may also enter the deep airways, according to a study.

Patsy Stinchfield, RN, MS, and William Schaffner, MD

April 2nd 2022

NFID Board Members Discuss Solutions to RSV-Related Disparities

Hayden E. Klein

William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, discuss health care disparities related to respiratory syncytial virus (RSV), as well as solutions to close these gaps.

April 1st 2022

Researchers Develop 51-Item Framework for Cough Severity Measurement

Hayden E. Klein

Urge-to-cough and cough symptoms were the 2 main domains of a 51-item framework to measure cough severity.

March 25th 2022

Record High Pediatric Parainfluenza Virus Incidence in Finland

Hayden E. Klein

Monthly parainfluenza virus incidence rates were nearly 6 times higher in September 2021 vs the second highest reported monthly incidence rates among children 4 years and younger in Finland in the last decade, following lifting of COVID-19–related restrictions.

March 23rd 2022

Dr Roxana Siles Discusses the Complexity of Managing Patients With Chronic Cough

Maggie L. Shaw

Roxana Siles, MD, FAAAAI, codirector of the Asthma Center at Cleveland Clinic, discusses the challenges of managing patients with chronic cough.

William Schaffner, MD, and Patsy Stinchfield, RN, MS, CPNP

March 19th 2022

NFID Board Members: We Need More Accessible, Less Expensive RSV Testing

Hayden E. Klein

William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain how COVID-19 testing developments have opened doors for developments in respiratory syncytial virus (RSV) testing.

March 14th 2022

Study Finds Electronic Clinical Decision Support Tool Improves Mortality in Patients With Pneumonia

Julia Bonavitacola

A recent study found that an electronic tool that guides diagnosis and treatment can reduce mortality and improve processes of care.

March 11th 2022

Study Finds Better Outcomes When Patients Admitted With ARF Have Quick Inter-ICU Transfers

Julia Bonavitacola

A retrospective, quasi-experimental study found that patients admitted to the intensive care unit (ICU) for acute respiratory failure (ARF) saw better outcomes when an inter-ICU transfer came within the first 2 days of admittance.

March 2nd 2022

Nirsevimab Protects Late-Preterm, Term Infants From RSV-Related Lower RTI, Study Finds

Hayden E. Klein

A phase 3 trial showed that nirsevimab was effective in preventing respiratory syncytial virus (RSV)-associated lower respiratory tract infection in healthy late-preterm and term infants.

February 28th 2022

What We're Reading: CDC Mask Guidance Loosened; RSV Vaccine Trial Halted; US Transplant System Reform

AJMC Staff

New CDC guidance says that Americans who live in areas with low to medium COVID-19 transmission can stop wearing masks indoors; GlaxoSmithKline (GSK) halts 3 vaccine clinical trials for the respiratory syncytial virus in pregnant women; a scientific advisory panel recommends a major overhaul of the US transplant system.

February 27th 2022

NFID Board Members on How RSV Affects Different Age Groups

Hayden E. Klein

William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, discuss how respiratory syncytial virus (RSV) affects different age groups.

February 24th 2022

AMA President Reflects on Lessons Learned, Future Challenges After 2 Years of COVID-19

Gianna Melillo

In this National Press Club address, American Medical Association President Gerald E Harmon, MD, outlines what steps need to be taken to better prepare the nation for the next pandemic.

February 23rd 2022

Transesophageal Echocardiography Not Linked With Respiratory Failure, Study Finds

Hayden E. Klein

The 28-day cumulative risk of respiratory failure after transesophageal echocardiography (TEE) was similar to the risk measured in those go did not undergo TEE, a procedure performed after a transient ischemic attack or stroke.

February 20th 2022

Small Study Shows 100% Success in Lung Transplants for COVID-19–Associated ARDS

Hayden E. Klein

Survival was 100% among patients who had COVID-19-associated acute respiratory distress syndrome (ARDS), and 83% for those without COVID-19 infection.

February 16th 2022

NFID Board Members Discuss COVID-19's Impact on RSV Seasonality

Hayden E. Klein

William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, explain how the COVID-19 pandemic has had an impact on the seasonality of respiratory syncytial virus (RSV).

February 14th 2022

Shorter Treatment for Community-Acquired Pneumonia as Effective as Longer Course

Hayden E. Klein

Research suggests a shorter 5-day antibiotic regimen for childhood community-acquired pneumonia, instead of 10 days, can optimize treatment efficacy while reducing unnecessary antibiotic use.

Nurse and patient walking in hospital hallway

February 5th 2022

Study Finds Higher In-Hospital Mortality Risk for Older Patients With Frailty, COVID-19

Hayden E. Klein

Research showed that younger and nonfrail patients with COVID-19 were more likely to be put on a ventilator, while patients with frailty and older age had a higher risk of in-hospital and in-ICU mortality.

February 4th 2022

Controversial Paper Claims COVID-19 "Lockdowns" Had Little Public Health Effect

Laura Joszt, MA

A meta-analysis from 3 economists concluded that nonpharmaceutical interventions in response to COVID-19 failed to have a large, significant effect on mortality rates.

February 3rd 2022

Antibiotic Practice Patterns With Procalcitonin Levels in Patients With Acute Lower Respiratory Tract Infection

Jessica K. Costales-Cantrell, DO, MBS Joanie Chung, MPH Jim H. Nomura, MD Kristen R. Ironside, MS Paul W. Salama, MD John J. Sim, MD

Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with regularity and also prioritize clinical judgment over PCT results.

February 2nd 2022

What We’re Reading: Cancer Moonshot Returns; New Omicron Subvariant; Drug Overdose Suicide Rates

AJMC Staff

President Biden announced he would bring back the Cancer Moonshot initiative that launched in the Obama administration; the World Health Organization said the Omicron subvariant, BA.2, appears to have the same severity as the original Omicron variant; cases of suicide by drug overdose increased in young people, older adults, and non-Hispanic Black women.

January 27th 2022

Review Evaluates Factors of Pulmonary Disease Subtype Development

Hayden E. Klein

The review discussed the roles of sex, ancestry, senescence, and aging in the development of nontuberculous mycobacterial pulmonary disease.

January 26th 2022

What We’re Reading: Long-term COVID-19 Factors; Rhode Island Joins Opioid Settlement Case; EPA and "Cancer Alley"

AJMC Staff

A study found 4 factors may correlate with increased risk of long-term COVID-19; Rhode Island joins opioid settlement against McKesson, AmerisourceBergen, and Cardinal Health; the Environmental Protection Agency announced it will station mobile equipment in Louisiana to measure air pollution.

January 25th 2022

What We're Reading: Ineffective COVID-19 Drugs; Panel Advises Fourth Dose in Israel; Physician Mental Health Amid Pandemic

AJMC Staff

FDA significantly restricts the use of 2 COVID-19 monoclonal antibody treatments ineffective against the Omicron variant; an expert panel advises the Israeli government to offer a fourth COVID-19 vaccine dose to adults; there was a substantial increase in visits for mental health and substance abuse among physicians with no prior history during the pandemic.

January 19th 2022

Study Highlights Health, Economic Benefits of RSV Vaccine for Older Adults

Hayden E. Klein

With no existing respiratory syncytial virus (RSV) vaccine yet, researchers found that a vaccine comparable with the influenza vaccine could prevent tens of thousands of hospitalizations and deaths per year.

<1 2 3 4 5 6 7 8 9 10

...

22 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions